Blackburn Exercises in Type-1 Scapular Dyskinesia
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Feb 5, 2021
Trial Information
Current as of September 10, 2025
Completed
Keywords
ClinConnect Summary
The shoulder joint plays an important role in the function of the upper limb and in the activities of daily living. Shoulder pathologies are very common with the lifetime risk being between 40% and 60%. Prevalence rates of shoulder disorders are approximately 70% as compared to other musculoskeletal conditions. Ideal motion of scapula plays a major role in the shoulder functioning, any variation in the kinematics of scapula leads to various pathologies in shoulder and alteration in the scapular positioning can affect pain in the shoulder. Loss in the rhythmic functionality of the scapula du...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Type-1 Scapular Dyskinesia patients with shoulder related causes
- • Positive scapular assistance test
- • Bilateral difference \> 1.5 cm in Lateral Scapular Slide Test
- Exclusion Criteria:
- • Non-shoulder related scapular dyskinesia
- • Recent fracture or trauma
- • Malignancy
- • Severe systemic illness
- • Corticosteroid injections in the affected shoulder in the preceding 6-9 weeks
- • Any other medically diagnoses orthopaedic, neurological or cardiovascular disorder affecting upper extremity function
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
Rawalpindi, Punjab, Pakistan
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Saira Waqqar, PHD*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials